Pulmonx (LUNG) Return on Equity (2020 - 2025)
Pulmonx (LUNG) has disclosed Return on Equity for 6 consecutive years, with 0.88% as the latest value for Q3 2025.
- Quarterly Return on Equity fell 29.0% to 0.88% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.88% through Sep 2025, down 29.0% year-over-year, with the annual reading at 0.55% for FY2024, 11.0% down from the prior year.
- Return on Equity for Q3 2025 was 0.88% at Pulmonx, down from 0.78% in the prior quarter.
- The five-year high for Return on Equity was 0.17% in Q1 2021, with the low at 0.88% in Q3 2025.
- Average Return on Equity over 5 years is 0.47%, with a median of 0.44% recorded in 2023.
- The sharpest move saw Return on Equity fell -11bps in 2022, then fell -29bps in 2025.
- Over 5 years, Return on Equity stood at 0.18% in 2021, then plummeted by -104bps to 0.37% in 2022, then dropped by -17bps to 0.44% in 2023, then crashed by -44bps to 0.63% in 2024, then tumbled by -40bps to 0.88% in 2025.
- According to Business Quant data, Return on Equity over the past three periods came in at 0.88%, 0.78%, and 0.7% for Q3 2025, Q2 2025, and Q1 2025 respectively.